368 related articles for article (PubMed ID: 32999024)
21. Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.
Klasse PJ; LaBranche CC; Ketas TJ; Ozorowski G; Cupo A; Pugach P; Ringe RP; Golabek M; van Gils MJ; Guttman M; Lee KK; Wilson IA; Butera ST; Ward AB; Montefiori DC; Sanders RW; Moore JP
PLoS Pathog; 2016 Sep; 12(9):e1005864. PubMed ID: 27627672
[TBL] [Abstract][Full Text] [Related]
22. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
[TBL] [Abstract][Full Text] [Related]
23. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
24. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.
Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR
Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.
Sanders RW; van Gils MJ; Derking R; Sok D; Ketas TJ; Burger JA; Ozorowski G; Cupo A; Simonich C; Goo L; Arendt H; Kim HJ; Lee JH; Pugach P; Williams M; Debnath G; Moldt B; van Breemen MJ; Isik G; Medina-Ramírez M; Back JW; Koff WC; Julien JP; Rakasz EG; Seaman MS; Guttman M; Lee KK; Klasse PJ; LaBranche C; Schief WR; Wilson IA; Overbaugh J; Burton DR; Ward AB; Montefiori DC; Dean H; Moore JP
Science; 2015 Jul; 349(6244):aac4223. PubMed ID: 26089353
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
de Taeye SW; Go EP; Sliepen K; de la Peña AT; Badal K; Medina-Ramírez M; Lee WH; Desaire H; Wilson IA; Moore JP; Ward AB; Sanders RW
J Biol Chem; 2019 Apr; 294(14):5616-5631. PubMed ID: 30728245
[TBL] [Abstract][Full Text] [Related]
27. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
Schiffner T; Pallesen J; Russell RA; Dodd J; de Val N; LaBranche CC; Montefiori D; Tomaras GD; Shen X; Harris SL; Moghaddam AE; Kalyuzhniy O; Sanders RW; McCoy LE; Moore JP; Ward AB; Sattentau QJ
PLoS Pathog; 2018 May; 14(5):e1006986. PubMed ID: 29746590
[TBL] [Abstract][Full Text] [Related]
28. Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies.
Bale S; Martiné A; Wilson R; Behrens AJ; Le Fourn V; de Val N; Sharma SK; Tran K; Torres JL; Girod PA; Ward AB; Crispin M; Wyatt RT
Front Immunol; 2018; 9():1116. PubMed ID: 29881382
[TBL] [Abstract][Full Text] [Related]
29. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
Torrents de la Peña A; Rantalainen K; Cottrell CA; Allen JD; van Gils MJ; Torres JL; Crispin M; Sanders RW; Ward AB
PLoS Pathog; 2019 Jul; 15(7):e1007920. PubMed ID: 31306470
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.
Ringe RP; Cruz Portillo VM; Dosenovic P; Ketas TJ; Ozorowski G; Nogal B; Perez L; LaBranche CC; Lim J; Francomano E; Wilson IA; Sanders RW; Ward AB; Montefiori DC; Nussenzweig MC; Klasse PJ; Cupo A; Moore JP
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852794
[TBL] [Abstract][Full Text] [Related]
31. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
J Virol; 2017 May; 91(10):. PubMed ID: 28275193
[TBL] [Abstract][Full Text] [Related]
32. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
Crooks ET; Tong T; Chakrabarti B; Narayan K; Georgiev IS; Menis S; Huang X; Kulp D; Osawa K; Muranaka J; Stewart-Jones G; Destefano J; O'Dell S; LaBranche C; Robinson JE; Montefiori DC; McKee K; Du SX; Doria-Rose N; Kwong PD; Mascola JR; Zhu P; Schief WR; Wyatt RT; Whalen RG; Binley JM
PLoS Pathog; 2015 May; 11(5):e1004932. PubMed ID: 26023780
[TBL] [Abstract][Full Text] [Related]
33. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
[TBL] [Abstract][Full Text] [Related]
34. An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability.
van Gils MJ; van den Kerkhof TL; Ozorowski G; Cottrell CA; Sok D; Pauthner M; Pallesen J; de Val N; Yasmeen A; de Taeye SW; Schorcht A; Gumbs S; Johanna I; Saye-Francisco K; Liang CH; Landais E; Nie X; Pritchard LK; Crispin M; Kelsoe G; Wilson IA; Schuitemaker H; Klasse PJ; Moore JP; Burton DR; Ward AB; Sanders RW
Nat Microbiol; 2016 Nov; 2():16199. PubMed ID: 27841852
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Dubrovskaya V; Tran K; Ozorowski G; Guenaga J; Wilson R; Bale S; Cottrell CA; Turner HL; Seabright G; O'Dell S; Torres JL; Yang L; Feng Y; Leaman DP; Vázquez Bernat N; Liban T; Louder M; McKee K; Bailer RT; Movsesyan A; Doria-Rose NA; Pancera M; Karlsson Hedestam GB; Zwick MB; Crispin M; Mascola JR; Ward AB; Wyatt RT
Immunity; 2019 Nov; 51(5):915-929.e7. PubMed ID: 31732167
[TBL] [Abstract][Full Text] [Related]
36. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ
Retrovirology; 2014 May; 11():41. PubMed ID: 24884783
[TBL] [Abstract][Full Text] [Related]
37. The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
Charles TP; Burton SL; Arunachalam PS; Cottrell CA; Sewall LM; Bollimpelli VS; Gangadhara S; Dey AK; Ward AB; Shaw GM; Hunter E; Amara RR; Pulendran B; van Gils MJ; Derdeyn CA
PLoS Pathog; 2021 Feb; 17(2):e1009257. PubMed ID: 33556148
[TBL] [Abstract][Full Text] [Related]
38. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization.
Bianchi M; Turner HL; Nogal B; Cottrell CA; Oyen D; Pauthner M; Bastidas R; Nedellec R; McCoy LE; Wilson IA; Burton DR; Ward AB; Hangartner L
Immunity; 2018 Aug; 49(2):288-300.e8. PubMed ID: 30097292
[TBL] [Abstract][Full Text] [Related]
39. High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination.
Dingens AS; Pratap P; Malone K; Hilton SK; Ketas T; Cottrell CA; Overbaugh J; Moore JP; Klasse PJ; Ward AB; Bloom JD
Elife; 2021 Jan; 10():. PubMed ID: 33438580
[TBL] [Abstract][Full Text] [Related]
40. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
